Real-time enrollment status for this ovarian cancer, epithelial clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 10:01 PM UTC
| NCT Number | NCT05107674 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer, Epithelial |
| Phase | PHASE1 |
| Target Enrollment | 345 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Nurix Therapeutics, Inc. |
| Last Updated on CT.gov | September 9, 2025 (Sep 9, 2025) |
As of October 12, 2026: Clinical trial NCT05107674 is currently recruiting participants. This phase1 study for ovarian cancer, epithelial is actively seeking new participants at 10 locations across the United States. The study is sponsored by Nurix Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05107674 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05107674 was last updated Sep 9, 2025 (September 9, 2025). HelloStudys verifies this status automatically.